P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same

摘要

The disclosure relates to an effective p-glycoprotein inhibitor compound of formula (I) and a pharmaceutically acceptable salt thereof, a method for preparing the same and a pharmaceutical composition containing the same as an active ingredient. The bioavailability of an anticancer agent is enhanced when the anticancer agent is administered together with a pharmaceutical composition comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof by suppressing p-glycoprotein.